INmune Bio, Inc. (INMB) Financials
INMB Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 25.8 million | 6.2 million |
| Dec. 31, 2025 | 32.4 million | 8.8 million |
| Sept. 30, 2025 | 33.4 million | 8.0 million |
| June 30, 2025 | 37.7 million | 8.8 million |
INMB Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -3.4 million | 1.5 million |
| Dec. 31, 2025 | -3.7 million | -6.6 million |
| Sept. 30, 2025 | -5.6 million | 3.0 million |
| June 30, 2025 | -8.1 million | 1.5 million |
INMB Net Income
No data available :(
INMB Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 21.4 million | - | 806000 |
| Dec. 31, 2025 | 24.8 million | - | 1.0 million |
| Sept. 30, 2025 | 27.7 million | - | 1.1 million |
| June 30, 2025 | 33.4 million | - | 451000 |
INMB Shares Outstanding
INMB Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 3.6 million | 2.2 million | - |
| Dec. 31, 2025 | 705999 | 2.3 million | 3.1 million | - |
| Sept. 30, 2025 | 193000 | 4.9 million | 2.5 million | - |
| June 30, 2025 | 705999 | 5.8 million | 2.3 million | - |
INMB Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | 52000 |
| Dec. 31, 2025 | - | 56000 |
| Sept. 30, 2025 | - | 28000 |
| June 30, 2025 | - | - |
INMB
Price: $1.45
52 week price:
Earnings Per Share: -1.63 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 49961
Market Capitalization: 36.2 million